By: Donald “D.” Taylor, Las Vegas
I applaud the push to rein in insulin prices [“Lawmakers scrutinize cost of insulin,” news, June 23]. In Nevada, we are way ahead of Washington when it comes to sending a message to Big Pharma that enough is enough.
This month, the Republican governor of Nevada, Brian Sandoval, signed a first-in-the-nation insulin pricing transparency law. The political power behind the law’s passage included an unprecedented coalition of big business, labor unions (led by Unite Here) and citizen advocates.
The new law requires manufacturers to report their costs for producing and marketing insulin and requires pharmaceutical sales representatives to report interactions with doctors, including whom they visited and what gifts they gave.